UnknownNCT04191226
Genetic Mutation in Recurrent Cervical Cancer
Studying Genetic urogenital tumor
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Lei Li
- Principal Investigator
- Lei LiPeking Union Medical College Hospital
- Intervention
- Multi-gene panel testing(diagnostic_test)
- Enrollment
- 300 target
- Eligibility
- 18 years · FEMALE
- Timeline
- 2019 – 2023
Study locations (1)
- Lei Li, Beijing, Beijing Municipality, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04191226 on ClinicalTrials.govOther trials for Genetic urogenital tumor
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06046131Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression.Centre Hospitalier Universitaire de la Guadeloupe
- RECRUITINGPHASE2NCT03833921Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate CancerMartha Mims
- ACTIVE NOT RECRUITINGNCT03158922The BARCODE 1 Pilot StudyInstitute of Cancer Research, United Kingdom
- ACTIVE NOT RECRUITINGPHASE1NCT00977457Genetic Testing in Predicting Biomarkers of Recurrence in Patients With Prostate Cancer Undergoing SurgeryCity of Hope Medical Center